Molecular modeling of beta-cyclodextrin complexes with nootropic drugs

J Pharm Sci. 1992 Dec;81(12):1157-61. doi: 10.1002/jps.2600811205.

Abstract

The geometry and structural features of the inclusion complexes of beta-cyclodextrin (beta-CD) with the chiral antiamnesic drugs (+/-)-1-benzyl-4-hydroxymethylpyrrolidin-2-one (WEB-1868). (+/-)-1-benzenesulfonyl-5-ethoxypyrrolidin-2-one (RU-35929), and (+/-)-1-(3-pyridinlysulfonyl)-5-ethoxypyrrolidin-2-one (RU-47010) were studied by the molecular modeling method (MacroModel interactive computer program). Docking procedures yielded the most stable complexes, which showed the aromatic ring of the guests inside the cavity and the pyrrolidinone ring out from the side of the beta-CD secondary hydroxyl groups. The binding energies were essentially due to hydrogen-bonded structures involving the C=O group of the guests. Selective interactions allowed chiral discrimination, and accordingly, separate beta-CD complexes of the R and S enantiomers of each guest compound were studied. The almost round beta-CD structure, in all the cases, assumed an elliptic shape on passing from the isolated molecule to the docked complex. The optimized structures and conformations of beta-CD and its inclusion compounds showed acceptable general agreement with information from proton nuclear magnetic resonance studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Computer Simulation*
  • Cyclodextrins / chemistry*
  • Magnetic Resonance Spectroscopy / methods
  • Models, Chemical*
  • Models, Molecular
  • Molecular Conformation
  • Psychotropic Drugs / chemistry*
  • Sensitivity and Specificity
  • Stereoisomerism
  • beta-Cyclodextrins*

Substances

  • Cyclodextrins
  • Psychotropic Drugs
  • beta-Cyclodextrins
  • betadex